These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 36314972)

  • 1. Permeability of TB drugs through the mycolic acid monolayer: a tale of two force fields.
    Basu S; Mandal S; Maiti PK
    Phys Chem Chem Phys; 2024 Aug; 26(32):21429-21440. PubMed ID: 39101468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and optimization of pyridine carboxamide-based scaffold as a drug lead for
    Singh P; Kumar A; Sharma P; Chugh S; Kumar A; Sharma N; Gupta S; Singh M; Kidwai S; Sankar J; Taneja N; Kumar Y; Dhiman R; Mahajan D; Singh R
    Antimicrob Agents Chemother; 2024 Feb; 68(2):e0076623. PubMed ID: 38193667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unravelling the potential of Triflusal as an anti-TB repurposed drug by targeting replication protein DciA.
    Ali W; Jamal S; Gangwar R; Ahmed F; Pahuja I; Sharma R; Prakash Dwivedi V; Agarwal M; Grover S
    Microbes Infect; 2024; 26(3):105284. PubMed ID: 38145750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing of anti-malarial drugs for the treatment of tuberculosis: realistic strategy or fanciful dead end?
    Hanscheid T; Del Portal Luyten CR; Hermans SM; Grobusch MP
    Malar J; 2024 May; 23(1):132. PubMed ID: 38702649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of essential mycobacterial replication enzyme DnaG primase revealed Mitoxantrone and Vapreotide as novel mycobacterial growth inhibitors.
    Ali W; Jamal S; Gangwar R; Ahmed F; Sharma R; Agarwal M; Sheikh JA; Grover A; Grover S
    Mol Inform; 2024 Mar; 43(3):e202300284. PubMed ID: 38123523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid and thioacetazone may exhibit antitubercular activity by binding directly with the active site of mycolic acid cyclopropane synthase: Hypothesis based on computational analysis.
    Banerjee D; Bhattacharyya R
    Bioinformation; 2012; 8(16):787-9. PubMed ID: 23055630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel thiosemicarbazone derivatives with potent and selective anti-
    Li X; Li L; Zhang H; Chi X; Jiang Y; Ni T
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2202362. PubMed ID: 37080774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biosynthesis and regulation of mycolic acids in Mycobacterium tuberculosis--a review].
    Luo H; Pang L; Xie J
    Wei Sheng Wu Xue Bao; 2012 Feb; 52(2):146-51. PubMed ID: 22586991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSC19723, a Thiacetazone-Like Benzaldehyde Thiosemicarbazone Improves the Efficacy of TB Drugs
    Singh P; Rawat S; Agrahari AK; Singh M; Chugh S; Gurcha S; Singh A; Abrahams K; Besra GS; Asthana S; Rawat DS; Singh R
    Microbiol Spectr; 2022 Dec; 10(6):e0259222. PubMed ID: 36314972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new tuberculosis drug Perchlozone® shows cross-resistance with thiacetazone.
    Gopal P; Dick T
    Int J Antimicrob Agents; 2015 Apr; 45(4):430-3. PubMed ID: 25704063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, antitubercular activity and mechanism of resistance of highly effective thiacetazone analogues.
    Coxon GD; Craig D; Corrales RM; Vialla E; Gannoun-Zaki L; Kremer L
    PLoS One; 2013; 8(1):e53162. PubMed ID: 23301038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone.
    Grzegorzewicz AE; Korduláková J; Jones V; Born SE; Belardinelli JM; Vaquié A; Gundi VA; Madacki J; Slama N; Laval F; Vaubourgeix J; Crew RM; Gicquel B; Daffé M; Morbidoni HR; Brennan PJ; Quémard A; McNeil MR; Jackson M
    J Biol Chem; 2012 Nov; 287(46):38434-41. PubMed ID: 23002234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the essential FAS II β-hydroxyacyl ACP dehydratase complex confer resistance to thiacetazone in Mycobacterium tuberculosis and Mycobacterium kansasii.
    Belardinelli JM; Morbidoni HR
    Mol Microbiol; 2012 Nov; 86(3):568-79. PubMed ID: 22994892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.